Editas Medicine Inc (EDIT)
6.005
+0.32
(+5.72%)
USD |
NASDAQ |
May 15, 15:12
Editas Medicine Shares Outstanding: 82.24M for May 3, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 03, 2024 | 82.24M |
April 02, 2024 | 82.23M |
March 31, 2024 | 82.24M |
February 23, 2024 | 81.81M |
December 31, 2023 | 81.77M |
October 27, 2023 | 81.67M |
September 30, 2023 | 81.67M |
July 28, 2023 | 81.63M |
June 30, 2023 | 81.62M |
June 20, 2023 | 81.53M |
May 31, 2023 | 69.03M |
April 28, 2023 | 69.00M |
April 04, 2023 | 68.99M |
March 31, 2023 | 68.99M |
February 17, 2023 | 68.97M |
December 31, 2022 | 68.85M |
October 28, 2022 | 68.76M |
September 30, 2022 | 68.76M |
July 29, 2022 | 68.74M |
June 30, 2022 | 68.72M |
April 29, 2022 | 68.64M |
April 12, 2022 | 68.64M |
March 31, 2022 | 68.60M |
February 14, 2022 | 68.52M |
December 31, 2021 | 68.44M |
Date | Value |
---|---|
November 05, 2021 | 68.40M |
September 30, 2021 | 68.32M |
July 30, 2021 | 68.26M |
June 30, 2021 | 68.16M |
April 30, 2021 | 67.83M |
April 06, 2021 | 67.58M |
March 31, 2021 | 67.47M |
February 14, 2021 | 67.36M |
January 25, 2021 | 66.37M |
January 11, 2021 | 62.87M |
December 31, 2020 | 62.56M |
October 30, 2020 | 62.33M |
September 30, 2020 | 62.19M |
July 31, 2020 | 62.27M |
June 30, 2020 | 62.10M |
June 26, 2020 | 61.95M |
May 31, 2020 | 55.05M |
May 01, 2020 | 54.82M |
April 30, 2020 | 54.82M |
April 15, 2020 | 54.98M |
April 01, 2020 | 54.98M |
March 31, 2020 | 54.80M |
February 14, 2020 | 54.88M |
December 31, 2019 | 54.36M |
November 01, 2019 | 51.30M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
49.24M
Minimum
Jun 30 2019
82.24M
Maximum
May 03 2024
66.72M
Average
68.32M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Vertex Pharmaceuticals Inc | 258.05M |
Bristol-Myers Squibb Co | 2.027B |
Regeneron Pharmaceuticals Inc | 110.19M |
Cabaletta Bio Inc | 48.24M |
Oragenics Inc | 4.481M |